Document is current
Any future updates will be listed below
-
Authors
Armstrong, Sarah C.
Windom, McAllister
Bihlmeyer, Nathan A.
Li, Jennifer S.
Shah, Svati H.
Story, Mary
Zucker, Nancy
Kraus, William E.
Pagidipati, Neha
Peterson, Eric
Wong, Charlene
Wiedemeier, Manuela
Sibley, Lauren
Berchuck, Samuel I.
Merrill, Peter
Zizzi, Alexandra
Sarria, Charles
Dressman, Holly K.
Rawls, John F.
Skinner, Asheley C. https://orcid.org/0000-0002-7737-9181
-
Funding
Funding for this research was provided by:
American Heart Association (17SFRN33700117, 17SFRN33670990, 17SFRN33671003, 17SFRN33700155)
- License Information
-
More Information
Article History
Received: 14 April 2020
Accepted: 2 June 2020
First Online: 26 June 2020
Ethics approval and consent to participate
: The proposed intervention, by focusing on implementing health behaviors recommended by current clinical practice guidelines, does not expose study participants to significant risk and does not significantly prolong enrollment in the intervention. Parent consent was obtained for all participants under age 18, as well as assent from the child. The study protocol and other relevant study materials have been reviewed and approved by the Duke Institutional Review Board. (Pro00086684 & Pro00074547).
: Not applicable.
: <b>Sarah C. Armstrong:</b> Dr. Armstrong has research supported by Astra Zeneca. She is a member of the Data Safety and Monitoring Committee for Novo Nordisk. She is a paid speaker for Rhythm Pharmaceuticals.<b>McAllister Windom:</b> Declaration of interest—none.<b>Nathan A. Bihlmeyer</b>: Declaration of interest—none.<b>Jennifer S. Li:</b> Declaration of interest—none.<b>Svati H. Shah:</b> Declaration of interest—none.<b>Mary Story:</b> Declaration of interest—none.<b>Nancy Zucker:</b> Declaration of interest—none.<b>William E. Kraus:</b> Declaration of interest—none.<b>Neha Pagidipati:</b> Dr. Pagidipati reports research grants from: Alexion Pharmaceuticals, Inc.; Amarin Pharmaceutical Company; Amgen, Inc.; AstraZeneca; Baseline Study LLC; Boehringer Ingleheim; Duke Clinical Research Institute; Eli Lilly & Company; Novo Nordisk Pharmaceutical Company; Regeneron Pharmaceuticals, Inc.; Sanofi-S.A.; Verily Sciences Research Company. She reports consulting fees from AstraZeneca.<b>Eric Peterson:</b> Dr. Peterson Receives research support from Amgen, Janssen, Astra Zeneca, and Sanofi and receives consulting support from Amgen, Sanofi, Janssen. He also is on the advisory board for Cerner and Livogo.<b>Charlene Wong:</b> Dr. Wong has research supported by Verily Life Sciences.<b>Manuela Wiedemeier:</b> Declaration of interest—none.<b>Lauren Sibley:</b> Declaration of interest—none.<b>Samuel Berchuck:</b> Declaration of interest—none.<b>Peter Merrill:</b> Declaration of interest—none.<b>Alexandra Zizzi:</b> Declaration of interest—none.<b>Charles Sarria:</b> Declaration of interest—none.<b>Holly K. Dressman</b>: Declaration of interest—none.<b>John F. Rawls:</b> Declaration of interest—none.<b>Asheley C. Skinner</b>: Declaration of interest—none.
